CD274 and intrahepatic cholangiocarcinoma: PD-L1/PD1 may be a valuable prognostic and predictive biomarker and potential therapeutic target in ICC.<h4>Systematic review registration</h4>https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022380093.